REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.59
+0.41 (4.47%)
At close: Nov 22, 2024, 4:00 PM
9.45
-0.14 (-1.46%)
After-hours: Nov 22, 2024, 6:01 PM EST
REGENXBIO Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$36.36
Upside
+279.14%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +442.23% | Nov 20, 2024 |
Morgan Stanley | Morgan Stanley | Buy Initiates $22 | Buy | Initiates | $22 | +129.41% | Nov 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +317.10% | Nov 7, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +442.23% | Oct 22, 2024 |
Raymond James | Raymond James | Buy Initiates $18 | Buy | Initiates | $18 | +87.70% | Oct 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +306.67% | Sep 4, 2024 |
Barclays | Barclays | Buy Maintains $55 → $50 | Buy | Maintains | $55 → $50 | +421.38% | Aug 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 → $39 | Strong Buy | Maintains | $38 → $39 | +306.67% | Aug 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +296.25% | Jun 20, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +296.25% | Jun 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +296.25% | May 15, 2024 |
Stifel | Stifel | Strong Buy Maintains $40 | Strong Buy | Maintains | $40 | +317.10% | Apr 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +275.39% | Mar 11, 2024 |
RBC Capital | RBC Capital | Hold → Buy Upgrades $20 → $35 | Hold → Buy | Upgrades | $20 → $35 | +264.96% | Mar 8, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +442.23% | Mar 7, 2024 |
Barclays | Barclays | Buy Maintains $45 → $55 | Buy | Maintains | $45 → $55 | +473.51% | Mar 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.